Revisions of 'Extra-adrenal pheochromocytoma'

• Revision 4 (current) - created 6 months ago by Henry Knipe - view changeset
  Date: 2022-09-29 20:56:54 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Radiopaedia Events Pty Ltd, Speaker fees (past)
  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Patrick O'Shea
• Revision 3 - created 6 months ago by Henry Knipe - view changeset
  Date: 2022-09-29 20:56:24 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Radiopaedia Events Pty Ltd, Speaker fees (past)
  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Patrick O'Shea
• Revision 2 - created 6 months ago by Rania Adel Anan - view changeset
  Date: 2022-09-27 23:58:50 UTC Disclosures:

  At the time the revision was created Rania Adel Anan had no financial relationships to ineligible companies to disclose.

  View Rania Adel Anan's current disclosures Reviewed by: Henry Knipe
• Revision 1 - created 6 months ago by Rania Adel Anan
  Date: 2022-09-27 22:57:54 UTC Disclosures:

  At the time the revision was created Rania Adel Anan had no financial relationships to ineligible companies to disclose.

  View Rania Adel Anan's current disclosures

Unfortunately some older revisions may not be able to be viewed or restored.